In 2022, the global Mammography Market is expected to be worth approximately US$ 1.7 billion. However, with the alarming rise in the prevalence of breast cancer, the overall demand for mammography systems is expected to grow at a 6.5% to 9% CAGR between 2022 and 2032, totalling more than US$ 3.4 billion by 2032.
Mammography is a non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to detect tumours in breast tissues. It has become one of the most widely used techniques for detecting abnormalities when there are no symptoms. It has significantly aided in the reduction of breast cancer mortality rates around the world.
The rising prevalence of breast cancer around the world, combined with growing awareness about the benefits of screening and early detection of breast cancer, is driving the mammography market forward. It is one of the most common types of cancer in females around the world.
Several studies have found that the risk of breast cancer increases with age and is more common in women over the age of 40. Because of this, medical institutes and organisations such as the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN) have recommended annual mammography screening for women beginning at the age of 40. This will continue to be a driving force in market growth in the future.
For the early detection of breast cancer, various mammography solutions or types, such as breast tomosynthesis, film screen systems, and X-ray, are used. However, film screen systems, also known as screen film mammography, continue to be the gold standard for detecting breast cancer.
Various government and non-government organisations are investing heavily in increasing breast cancer screening and, as a result, lowering the overall burden. This will continue to be a tailwind for market growth in the future. Furthermore, the presence of favourable reimbursement policies in many developed regions is positively impacting the growth of the mammography market.
Market Competition
Some of the key participants present in the global mammography market include Allengers Medical Systems Limited, FUJIFILM Holdings America Corporation, Hologic, Inc., PLANMED OY, Konica Minolta, GENERAL ELECTRIC, Inc., Siemens Healthcare Private Limited, Carestream Health, GE Healthcare, Koninklijke Philips N.V., and BET Medical.
These leading players are continuously innovating for developing novel diagnostic products with enhanced features and minimum side effects. Besides this, they are adopting growth strategies such as partnerships, acquisitions, collaborations, spending on awareness campaigns etc. to gain a competitive edge in the market.
Key Segments Profiled in the Mammography Industry Survey
By Product Type:
- Breast Tomosynthesis
- Film Screen Systems
- X-Ray
- Others
By Technology Type:
- Digital Mammography
- Analog Mammography
- 3-D Mammography
- 2-D Mammography
By End Use:
- Hospitals
- Special Clinics
- Diagnosis Centers
- Ambulatory Surgical Centers
- Educational & Research Institutes
Read More@ https://www.futuremarketinsights.com/reports/mammography-market
